Vanguard Capital Management
AMRX icon

Vanguard Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Vanguard Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133M Buy
7,710,126
+125,092
+2% +$1.71M ﹤0.01% 1392
2026
Q1 		$94.3M Buy
+7,585,034
New +$102M ﹤0.01% 1499

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management's AMRX Position: Q2 2026 in Review

Vanguard Capital Management increased its Amneal Pharmaceuticals (AMRX) stake by 1.6% in Q2 2026, buying an estimated $1.71M and bringing the position to 7,710,126 shares worth $133M. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

Vanguard Capital Management first reported a position in AMRX in Q1 2026 and has held it in 2 quarters since. 305 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Vanguard Capital Management held 7,710,126 shares of Amneal Pharmaceuticals worth $133M as of Q2 2026.
  • Vanguard Capital Management bought 125,092 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.71M.
  • Amneal Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1392 holding.
  • Vanguard Capital Management first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 305 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.